Tectonic Therapeutic TECX
NASDAQ TECX
$30.03 +0.11 (+0.37%)
As of: Sep 4, 2026 · 12:30 PM EDT

Tectonic Therapeutic (TECX) Other Operating Expenses (2023)

Tectonic Therapeutic (TECX) posted quarterly Other Operating Expenses of $83.7 million for Q2 2023, up 490.06% quarter-over-quarter from $14.2 million in Q4 2017.

Analysis

Tectonic Therapeutic (TECX) Other Operating Expenses (2023) Analysis & Trends

Tectonic Therapeutic (TECX) has reported Other Operating Expenses for 2 consecutive years, with $83.7 million the latest figure, recorded in Q2 2023.

  • In Q2 2023, Other Operating Expenses changed N/A year-over-year to $83.7 million; the TTM figure through Mar 2024 stood at $83.7 million (changed N/A YoY), while the FY2023 annual figure was $83.7 million, changed N/A from the prior year.
  • Other Operating Expenses rose to $83.7 million in Q2 2023 per TECX's latest filing, from $14.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $83.7 million in Q2 2023 and bottomed at $83.7 million in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Tectonic Therapeutic 569.49 Mn 569.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 83.74 Mn